查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014473

內視鏡超音波市場：依產品、技術、應用和最終用戶分類－2026-2032年全球市場預測

Endoscopy Ultrasound Market by Product, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內視鏡超音波市場價值將達到 12.1 億美元，到 2026 年將成長至 13.1 億美元，到 2032 年將達到 20.8 億美元，複合年成長率為 8.01%。

主要市場統計數據
基準年 2025 12.1億美元
預計年份：2026年 13.1億美元
預測年份 2032 20.8億美元
複合年成長率 (%) 8.01%

簡要概述技術創新和臨床實踐的進展如何重新定義超音波超音波在現代胃腸、胰臟和膽道醫學中的作用。

超音波（EUS）已發展成為連接內視鏡和斷層成像的關鍵診斷工具，可在複雜的胃腸道和胰膽疾病中提供高解析度視覺化和組織表徵。探頭設計、影像物理學和輔助技術的最新進展拓展了其適應症，提高了診斷準確性，創造了新的治療性介入機會，並重塑了多學科臨床流程。隨著診療趨勢向微創診斷和治療轉變，EUS 在分期、標靶切片檢查和引導介入治療中發揮日益重要的作用，縮短了診斷時間，並為後續的個人化治療方案製定提供了可能。

探頭創新、軟體驅動的影像處理和工作流程整合如何將超音波從診斷輔助手段轉變為主要手術手段。

由於探頭結構的改進、軟體輔助影像增強技術的應用以及介入操作從開放性手術手術室向內視鏡室的轉移，超音波內視鏡（EUS）領域正經歷著變革性的轉變。前視探頭、線陣探頭和徑向陣列探頭的設計進步提高了手術的靈活性，使臨床醫生能夠選擇能夠最佳化視野、針道軌跡並應對特定臨床挑戰的設備。同時，對比增強和彈性成像等影像處理技術的進步，以及3D重建技術和微型探頭的出現，提高了病灶的表徵能力和手術的可靠性。

評估 2025 年美國關稅調整超音波設備的採購、供應商策略和臨床可用性的營運和採購影響。

關稅變化和貿易政策調整會對醫療器材的整個生命週期產生連鎖反應，包括供應鏈、採購決策以及醫療保健產業的整個醫療設備生命週期。尤其是在美國，2025年實施的關稅調整表改變了某些醫療設備和組件的接收成本，迫使採購團隊和製造商重新評估籌資策略和合約條款。當進口關稅提高時，製造商和經銷商需要評估國內生產方案、區域物流策略以及與供應商的長期合約關係，以維持利潤率和供應鏈的連續性。

從綜合細分的觀點闡明產品類型、臨床適應症、影像技術和醫療保健環境如何相互作用，從而影響醫療設備的選擇和臨床使用。

細分市場分析揭示了產品、應用、技術和終端用戶趨勢如何相互作用，從而影響臨床應用和採購偏好。在比較前瞻性、線陣和徑向陣列探頭類型時，臨床團隊會優先考慮與其手術項目相關的設備屬性。具體而言，前瞻性探頭因其可直接用於治療而備受青睞，線陣探頭因其可用於針引導介入和採樣精度而備受青睞，而徑向陣列探頭則因其可用於環週解剖結構檢查和初步診斷定位而備受青睞。臨床醫生和採購負責人在為醫療機構選擇探頭套裝時，通常會考慮這些差異，並結合手術數量和臨床部門組成進行權衡。

美洲、歐洲、中東、非洲和亞太地區的區域法規環境、償還框架和基礎設施投資如何影響先進EUS技術的採用和部署策略？

區域趨勢持續影響全部區域的醫療技術應用軌跡和投資重點，每個地區都有其獨特的臨床促進因素、監管路徑和採購生態系統。在美洲，醫療機構在採購決策中往往優先考慮綜合服務支援、全面的維護合約以及能夠證明手術效率和臨床療效的證據。因此，這些機構優先選擇適用於高頻次三級醫療和複雜介入治療計畫的設備。支付模式和臨床指南的普及程度正在影響創新技術的優先排序和規模化推廣。

EUS 領域的競爭由豐富的產品系列、臨床夥伴關係和售後服務模式所驅動，這些因素會影響感知價值和採購決策。

EUS生態系內的競爭動態受多種因素驅動，包括產品線廣度、臨床證據、售後服務以及臨床夥伴關係。擁有豐富產品組合的成熟製造商通常透過全面的服務、整合的影像平台以及與大規模醫院系統的現有合作關係來脫穎而出。同時，創新新參與企業則專注於模組化設計、小眾影像模式以及針對特定臨床需求的標靶治療方案，從而形成一種互補而非零和的競爭環境。

為了確保 EUS 專案的成功擴展，設備團隊和臨床領導者需要採取切實可行的策略行動，以協調採購、培訓和互通性的優先事項。

醫療設備研發、醫院採購和臨床專案管理領域的領導者應採取協調一致、切實可行的方法，將洞察轉化為可衡量的成果。首先，應使器械選擇與手術方案和培訓系統相匹配，從而確保投資轉化為臨床柔軟性和更高的治療能力。採購團隊和臨床領導者之間協作制定器械規格和支援協議，有助於醫療機構更好地平衡資本支出與利用目標。

採用透明且多方面的研究途徑，結合對從業人員的訪談、對臨床文獻的回顧、監管分析和供應鏈評估，得出了可靠的、基於證據的結論。

本報告的調查方法結合了定性和定量方法，旨在全面了解臨床實踐、技術趨勢和商業性動態。主要研究包括對執業內視鏡醫師、介入性胃腸病學家、採購專家和臨床工程師進行結構化訪談，以收集第一線人員對設備性能、培訓需求和實施挑戰的觀點。輔助資訊包括同行評審的臨床文獻、監管文件、產品規格和公開的臨床指南，以支持從業人員的見解並闡明該技術的成熟路徑。

整合臨床、技術和營運趨勢，供政策制定者、臨床醫生和採購經理在加速負責任地部署先進的 EUS 能力時參考。

總之，內視鏡超音波正處於轉折點，由於技術的成熟、臨床對微創診斷的需求以及採購環境的變化，其臨床應用範圍正在擴大。探頭設計、造影和彈性成像技術以及3D成像技術的進步，提高了診斷準確性，並使內視鏡室能夠進行更安全、更複雜的操作。隨著醫療機構和醫療設備開發商適應供應鏈和政策的變化，協調投資於培訓、互通性和供應商關係對於技術的持續應用至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡超音波市場：依產品分類

  • 前瞻型
  • 線性陣列
  • 徑向陣列

第9章 內視鏡超音波市場：依技術分類

  • 造影增強
    • 微氣泡劑
    • 參數量化
  • 彈性成像
    • 剪切波
    • 失真
  • 微型探針
  • 3D EUS
    • 離線重配置
    • 即時3D

第10章 內視鏡超音波市場：依應用領域分類

  • 胃腸道腫瘤
  • 淋巴結分期
  • 胰臟和膽道疾病
  • 黏膜下腫瘤

第11章 內視鏡超音波市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院

第12章 內視鏡超音波市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 內視鏡超音波市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 內視鏡超音波市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國內視鏡超音波市場

第16章：中國內鏡超音波市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Olympus Corporation
  • Alpinion Medical Systems Co., Ltd.
  • B. Braun Melsungen AG
  • BK Medical
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Conmed Corporation
  • Cook Medical LLC
  • EndoSound, Inc.
  • Fujifilm Holdings Corporation
  • Hitachi, Ltd.
  • Huaco Healthcare Technologies Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • LeCroy
  • Medi-Globe GmbH
  • Medtronic plc
  • Mindray Medical International Limited
  • PENTAX Medical
  • Richard Wolf GmbH
  • Samsung Medison Co., Ltd.
  • Shenzhen Anke High-tech Co., Ltd.
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • SonoScape Medical Corp.
  • Teratech Corporation
Product Code: MRR-4348D129FA94

The Endoscopy Ultrasound Market was valued at USD 1.21 billion in 2025 and is projected to grow to USD 1.31 billion in 2026, with a CAGR of 8.01%, reaching USD 2.08 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.21 billion
Estimated Year [2026] USD 1.31 billion
Forecast Year [2032] USD 2.08 billion
CAGR (%) 8.01%

A concise orienting overview of how technological innovation and clinical practice evolution are redefining the role of endoscopic ultrasound in contemporary gastrointestinal and pancreatobiliary care

Endoscopic ultrasound (EUS) has evolved into a pivotal modality that bridges endoscopy and cross-sectional imaging to provide high-resolution visualization and tissue characterization in complex gastrointestinal and pancreatobiliary disease. Recent advances in probe designs, imaging physics, and adjunctive technologies have expanded indications, improved diagnostic yield, and created new interventional opportunities while reshaping multidisciplinary care pathways. As the procedural landscape shifts toward minimally invasive diagnostics and therapeutics, EUS plays an increasingly central role in staging, targeted biopsy, and guided interventions that reduce time to diagnosis and enable downstream personalized treatment planning.

Clinical adoption is being driven not only by improvements in image quality and accessory compatibility but also by heightened clinician experience and evolving training paradigms. Concurrently, device manufacturers are investing in ergonomics, probe versatility, and integrated imaging suites that support real-time decision-making. Regulatory frameworks and reimbursement policies are adapting to these clinical advances, influencing deployment priorities in hospitals, diagnostic centers, and ambulatory surgery settings. Taken together, these dynamics set the stage for a period of technology-driven clinical maturation in which EUS becomes more deeply embedded in standard diagnostic algorithms and interventional toolkits.

How probe innovation, software-enabled imaging, and workflow integration are collectively transforming endoscopic ultrasound from a diagnostic adjunct into a procedural mainstay

The EUS landscape is undergoing transformative shifts driven by improvements in probe architectures, software-enabled image enhancement, and the migration of interventional capabilities from open surgical suites into endoscopy suites. Advances in forward viewing, linear array, and radial array probe designs have expanded procedural versatility, enabling clinicians to select devices that optimize field of view, needle trajectory, and access for specific clinical tasks. Simultaneously, imaging enhancements such as contrast enhancement and elastography, along with the emergence of three-dimensional reconstruction techniques and mini probes, are enhancing lesion characterization and procedural confidence.

Integration of digital workflows and compatibility with ancillary devices is accelerating the translation of EUS into complex interventions, including targeted biopsies, drainage procedures, and tumor-directed therapies. Training programs and simulation technologies are evolving in parallel to reduce the learning curve and promote safer adoption of therapeutic applications. Health systems are responding by creating multidisciplinary pathways that incorporate EUS outcomes into tumor boards and care coordination. These shifts collectively signal a move from diagnostic adjunct to procedural mainstay, driven by patient-centered demands for less invasive, higher-precision care.

Assessing the operational and procurement impacts of the United States tariff adjustments in 2025 on device sourcing, supplier strategies, and clinical availability for endoscopic ultrasound

Tariff changes and trade policy adjustments can create ripple effects across supply chains, procurement decisions, and device lifecycles within the healthcare sector. In the United States specifically, revised tariff schedules implemented in 2025 have altered landed costs for certain medical devices and components, prompting procurement teams and manufacturers to reassess sourcing strategies and contract terms. When import duties increase, manufacturers and distributors evaluate domestic production options, regional logistics strategies, and long-term supplier commitments to preserve margins and maintain supply continuity.

Procurement teams are responding by intensifying supplier diversification, seeking closer collaboration on total landed cost visibility, and exploring consignment or risk-sharing agreements to mitigate short-term price volatility. Clinical programs are increasingly focused on articulating value through outcomes and efficiencies to justify procurement choices to hospital finance and supply chain committees. Meanwhile, device developers are accelerating design-for-manufacture initiatives and localization strategies to reduce exposure to tariff-driven cost increases and to enhance control over quality and delivery timelines. These adaptive measures aim to sustain device availability for critical diagnostic and interventional procedures despite trade-related headwinds.

Integrated segmentation perspectives revealing how product typologies, clinical indications, imaging technologies, and care settings jointly influence device selection and clinical utilization

Segmentation analysis illuminates how product, application, technology, and end-user dynamics interact to shape clinical adoption and purchasing preferences. When examining products across forward viewing, linear array, and radial array probe types, clinical teams prioritize device attributes tied to the procedural portfolio: forward viewing probes are valued for direct therapeutic access, linear arrays for needle-guided interventions and sampling precision, and radial arrays for circumferential anatomic surveys and initial diagnostic orientation. Clinicians and procurement professionals often balance these differences against procedural volumes and specialty mix when selecting a probe set for an institution.

Application-driven segmentation underscores differing clinical evidence needs across gastrointestinal tumors, lymph node staging, pancreatobiliary diseases, and submucosal tumors. For each application, diagnostic sensitivity, safe therapeutic access, and integration with multidisciplinary care pathways determine clinical value. Technology segmentation reveals nuanced adoption patterns for contrast enhancement, elastography, mini probes, and three-dimensional EUS, with contrast enhancement evaluated both at the agent level and through parameter quantification, and elastography adoption influenced by distinctions between shear wave and strain techniques. Three-dimensional EUS shows divergent clinical utility depending on whether offline reconstruction or real-time three-dimensional capability is available. Finally, end-user segmentation across ambulatory surgery centers, diagnostic centers, and hospitals highlights divergent capital investment profiles, procedural throughput expectations, and staffing models that drive which device configurations and service offerings are most practical for each care setting.

How regional regulatory environments, reimbursement frameworks, and infrastructure investments across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and deployment strategies for advanced EUS technologies

Regional dynamics continue to shape adoption trajectories and investment priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific, with each geography presenting distinct clinical drivers, regulatory pathways, and procurement ecosystems. In the Americas, institutional procurement tends to emphasize integrated service support, bundled maintenance agreements, and evidence demonstrating procedural efficiency and clinical outcomes, prompting systems to prioritize devices that align with high-volume tertiary care and complex interventional programs. Payment models and clinical guideline uptake influence how innovations are prioritized and scaled.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts, reimbursement variability, and infrastructure heterogeneity create a landscape in which device manufacturers must offer flexible commercial models and robust post-market data to support adoption in diverse settings. Capacity building and training partnerships can be particularly influential in expanding advanced applications beyond major urban centers. In the Asia-Pacific region, rapid investments in hospital infrastructure, increasing specialist capacity, and a strong emphasis on minimally invasive care accelerate uptake of advanced imaging adjuncts and therapeutic EUS procedures. Regional supply chain considerations, distribution networks, and localized service capabilities further determine how quickly new technologies are translated into routine clinical practice.

Competitive dynamics driven by product portfolio depth, clinical partnerships, and aftermarket service models that determine perceived value and procurement decisions in EUS

Competitive dynamics in the EUS ecosystem are influenced by a combination of product depth, clinical evidence, aftermarket services, and collaborative clinical partnerships. Established manufacturers with broad device portfolios often differentiate through comprehensive service offerings, integrated imaging platforms, and existing relationships with large hospital systems. At the same time, innovative entrants focus on modular designs, niche imaging modalities, and targeted therapeutic solutions that address specific clinical gaps, creating a complementary competitive set rather than a zero-sum environment.

Strategic alliances between device developers, imaging software providers, and clinical centers of excellence are accelerating evidence generation and shaping perceived value. Manufacturers that invest in clinician training, simulation, and procedural workflow optimization can accelerate adoption by reducing implementation friction. Moreover, aftermarket considerations such as warranty structures, consumable compatibility, and remote diagnostics increasingly inform procurement decisions, as health systems weigh the total cost of ownership against clinical performance and operational resilience.

Practical strategic actions for device teams and clinical leaders to align procurement, training, and interoperability priorities for successful EUS program expansion

Leaders in device development, hospital procurement, and clinical program management should pursue a set of coordinated, actionable approaches to convert insights into measurable outcomes. First, align device selection with procedural portfolios and training capacity to ensure that investments deliver clinical flexibility and incremental therapeutic capability. When procurement teams and clinical leadership co-design equipment specifications and support contracts, institutions can better balance capital commitments with utilization goals.

Second, prioritize interoperability and software-enabled workflow features that reduce procedure time and enhance diagnostic confidence, while investing in clinician training and simulation to shorten adoption curves. Third, develop supplier engagement strategies that incorporate risk-sharing on consumables, service-level guarantees, and local spare-part inventories to mitigate supply chain volatility. Fourth, invest in post-procedural outcome tracking that links EUS-derived diagnoses and interventions to downstream care pathways, enabling clearer value articulation to payers and institutional stakeholders. Collectively, these actions will help organizations capture clinical and operational benefits while managing cost and implementation risk.

A transparent and triangulated research approach combining practitioner interviews, clinical literature review, regulatory analysis, and supply chain assessment to ensure robust, evidence-based conclusions

The research methodology underpinning this report combined qualitative and quantitative methods to generate a comprehensive view of clinical practice, technology trends, and commercial dynamics. Primary research included structured interviews with practicing endoscopists, interventional gastroenterologists, procurement specialists, and clinical engineers to capture firsthand perspectives on device performance, training needs, and implementation challenges. Secondary sources encompassed peer-reviewed clinical literature, regulatory filings, product specifications, and publicly available clinical guidelines to corroborate practitioner insights and to map technology maturation pathways.

Analytical processes emphasized triangulation to validate findings across multiple data points, with attention to differentiation among product types, clinical indications, imaging modalities, and end-user environments. Supply chain analysis integrated trade policy changes and distribution architectures to assess operational risk. Case studies and representative clinical scenarios were employed to illustrate real-world implications of technology choices and workflow adaptations. Throughout, methodological rigor was maintained by documenting interview protocols, inclusion criteria for secondary sources, and the analytical frameworks used to synthesize evidence into actionable insights.

Synthesis of clinical, technological, and operational trajectories that policymakers, clinicians, and procurement leaders should consider when accelerating responsible adoption of advanced EUS capabilities

In closing, endoscopic ultrasound stands at an inflection point where technological maturation, clinical demand for less invasive diagnostics, and evolving procurement environments converge to expand its clinical footprint. Advancements in probe design, contrast and elastography techniques, and three-dimensional imaging are enhancing diagnostic precision and enabling more complex interventions to be performed safely within endoscopy suites. As institutions and device developers adapt to supply chain and policy shifts, coordinated investments in training, interoperability, and supplier relationships will be critical to sustaining adoption.

Decision-makers should treat these developments as an opportunity to modernize procedural pathways, strengthen multidisciplinary collaboration, and invest in outcome measurement to demonstrate value. By doing so, clinical programs can better position themselves to deliver high-quality, efficient care while navigating commercial and operational complexities. The insights compiled here provide a practical foundation for clinicians, procurement leaders, and device developers to refine strategy and accelerate responsible adoption of advanced EUS capabilities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopy Ultrasound Market, by Product

  • 8.1. Forward Viewing
  • 8.2. Linear Array
  • 8.3. Radial Array

9. Endoscopy Ultrasound Market, by Technology

  • 9.1. Contrast Enhancement
    • 9.1.1. Microbubble Agents
    • 9.1.2. Parameter Quantification
  • 9.2. Elastography
    • 9.2.1. Shear Wave
    • 9.2.2. Strain
  • 9.3. Mini Probes
  • 9.4. Three D EUS
    • 9.4.1. Offline Reconstruction
    • 9.4.2. Real Time Three D

10. Endoscopy Ultrasound Market, by Application

  • 10.1. Gastrointestinal Tumors
  • 10.2. Lymph Node Staging
  • 10.3. Pancreatobiliary Diseases
  • 10.4. Submucosal Tumors

11. Endoscopy Ultrasound Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals

12. Endoscopy Ultrasound Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Endoscopy Ultrasound Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Endoscopy Ultrasound Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Endoscopy Ultrasound Market

16. China Endoscopy Ultrasound Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Olympus Corporation
  • 17.6. Alpinion Medical Systems Co., Ltd.
  • 17.7. B. Braun Melsungen AG
  • 17.8. BK Medical
  • 17.9. Boston Scientific Corporation
  • 17.10. Canon Medical Systems Corporation
  • 17.11. Conmed Corporation
  • 17.12. Cook Medical LLC
  • 17.13. EndoSound, Inc.
  • 17.14. Fujifilm Holdings Corporation
  • 17.15. Hitachi, Ltd.
  • 17.16. Huaco Healthcare Technologies Co., Ltd.
  • 17.17. Johnson & Johnson Services, Inc.
  • 17.18. LeCroy
  • 17.19. Medi-Globe GmbH
  • 17.20. Medtronic plc
  • 17.21. Mindray Medical International Limited
  • 17.22. PENTAX Medical
  • 17.23. Richard Wolf GmbH
  • 17.24. Samsung Medison Co., Ltd.
  • 17.25. Shenzhen Anke High-tech Co., Ltd.
  • 17.26. Siemens Healthineers AG
  • 17.27. Smith & Nephew plc
  • 17.28. SonoScape Medical Corp.
  • 17.29. Teratech Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPY ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPY ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY FORWARD VIEWING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY FORWARD VIEWING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY FORWARD VIEWING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY RADIAL ARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY RADIAL ARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY RADIAL ARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MICROBUBBLE AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MICROBUBBLE AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MICROBUBBLE AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PARAMETER QUANTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PARAMETER QUANTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PARAMETER QUANTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SHEAR WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SHEAR WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SHEAR WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY STRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY STRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY STRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MINI PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MINI PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MINI PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY OFFLINE RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY OFFLINE RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY OFFLINE RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REAL TIME THREE D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REAL TIME THREE D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REAL TIME THREE D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GASTROINTESTINAL TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GASTROINTESTINAL TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GASTROINTESTINAL TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LYMPH NODE STAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LYMPH NODE STAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LYMPH NODE STAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PANCREATOBILIARY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PANCREATOBILIARY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PANCREATOBILIARY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBMUCOSAL TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBMUCOSAL TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBMUCOSAL TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)